NASDAQ:NUVA
Delisted
NuVasive Stock News
$39.75
+0 (+0%)
At Close: Nov 30, 2023
NuVasive, Inc. (NASDAQ:NUVA) to Post FY2021 Earnings of $1.77 Per Share, Piper Sandler Forecasts
06:42am, Monday, 15'th Nov 2021 Dakota Financial News
NuVasive, Inc. (NASDAQ:NUVA) Research analysts at Piper Sandler reduced their FY2021 EPS estimates for NuVasive in a research note issued to investors on Wednesday, November 10th. Piper Sandler analyst M. Obrien now forecasts that the medical device company will earn $1.77 per share for the year, down from their previous estimate of $2.19. Piper []
Brokerages Anticipate NuVasive, Inc. (NASDAQ:NUVA) Will Announce Earnings of $0.48 Per Share
01:16am, Monday, 15'th Nov 2021 Transcript Daily
Wall Street brokerages forecast that NuVasive, Inc. (NASDAQ:NUVA) will report earnings of $0.48 per share for the current quarter, Zacks Investment Research reports. Five analysts have made estimates for NuVasives earnings, with the lowest EPS estimate coming in at $0.43 and the highest estimate coming in at $0.52. NuVasive reported earnings per share of $0.59 []
UBS Group Trims NuVasive (NASDAQ:NUVA) Target Price to $54.00
08:14am, Sunday, 14'th Nov 2021 Dakota Financial News
NuVasive (NASDAQ:NUVA) had its target price decreased by UBS Group from $59.00 to $54.00 in a research report released on Wednesday morning, Price Targets.com reports. UBS Group currently has a sell rating on the medical device companys stock. Other research analysts have also issued research reports about the stock. Loop Capital started coverage on shares []
NuVasive (NUVA) Q3 Earnings Miss Estimates, 2021 Guidance Down
11:28am, Wednesday, 10'th Nov 2021
NuVasive (NUVA) reported lower-than-expected earnings and revenues with COVID-led headwinds and healthcare staffing shortages dampening the Q3 top-line growth.
NuVasive's Q3 Earnings Hit By COVID-19, Staff Shortage; Cuts FY21 Guidance
07:18am, Wednesday, 10'th Nov 2021
NuVasive Inc (NASDAQ: NUVA) reported Q3 net sales of $270.8 million, an 8.3% decrease on a reported and constant currency basis, missing the consensus of $291.79 million. "The third quarter presente
NuVasive, Inc. (NUVA) CEO Christopher Barry on Q3 2021 Results - Earnings Call Transcript
08:35pm, Tuesday, 09'th Nov 2021
NuVasive, Inc. (NUVA) CEO Christopher Barry on Q3 2021 Results - Earnings Call Transcript
NuVasive (NUVA) Misses Q3 Earnings and Revenue Estimates
07:49pm, Tuesday, 09'th Nov 2021
NuVasive (NUVA) delivered earnings and revenue surprises of -40.74% and -7.03%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
NuVasive: Q3 Earnings Insights
04:32pm, Tuesday, 09'th Nov 2021
NuVasive (NASDAQ:NUVA) reported its Q3 earnings results on Tuesday, November 9, 2021 at 04:00 PM. Here's what investors need to know about the announcement.
NuVasive Launches Latest Porous PEEK Implant for Posterior Spine Surgery
07:00am, Thursday, 14'th Oct 2021
SAN DIEGO, Oct. 14, 2021 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integr
NuVasive (NUVA) Expands Training Opportunities With New Center
10:03am, Monday, 27'th Sep 2021
NuVasive's (NUVA) East Coast Experience Center reflects the company's commitment to provide best quality surgeon education and training to enhance the standard of patient care in spine surgery.
5 Stocks to Deflect Delta Variant Curveball From Orthopedic Space
09:55am, Thursday, 23'rd Sep 2021
OrthoPediatrics (KIDS), Orthofix (OFIX), Zimmer Biomet (ZBH), Stryker (SYK) and SeaSpine (SPNE) are expected to hold ground despite a challenging business climate.
NuVasive Opens East Coast Experience Center in New York Metropolitan Area
07:00am, Thursday, 23'rd Sep 2021
SAN DIEGO, Sept. 23, 2021 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integr
NuVasive Partners with Scoliosis Research Society in Ongoing Double Diamond Sponsorship
07:00am, Wednesday, 22'nd Sep 2021
SAN DIEGO, Sept. 22, 2021 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integr
NuVasive (NUVA) is a Top-Ranked Growth Stock: Should You Buy?
11:32am, Monday, 06'th Sep 2021
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
NuVasive Announces New Executive Leadership Roles
04:10pm, Wednesday, 01'st Sep 2021
SAN DIEGO , Sept. 1, 2021 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integ